Lee Byung-heon (biochemist)

Lee Byung-Heon
Born
South Korea
Scientific career
FieldsBiochemistry, Molecular Biology
InstitutionsKyungpook National University
Korean name
Hangul
이병헌
Revised RomanizationI Byeongheon
McCune–ReischauerI Pyŏnghŏn

Lee Byung-heon (Korean이병헌) is a professor of biochemistry and cell biology in the school of medicine at Kyungpook National University (KNU), South Korea.[1][2] He received his M.D. license from Korean Medical Association in 1989. He received his B.S. from the school of medicine, KNU, in 1989, and his M.S. and Ph.D. in biochemistry from KNU in 1991 and 1995. He was an assistant professor in the school of medicine at Dongguk University in 1996–2001 and a visiting investigator in the Sanford-Burnham Medical Research Institute, La Jolla, United States, in 2001–2003. He joined KNU in 2003. He is currently a member of the Korean Society for Biochemistry and Molecular Biology, the American Association for Cancer Research, and the American Society of Molecular Imaging. His main research interest is "discovery of tissue-specific homing peptides using phage display and their applications to molecular imaging and targeted therapy". He is currently carrying out projects for the identification of homing peptides to tumor and atherosclerotic plaque and of phosphatidylserine- and blood clotting factor XIIIa-specific peptide ligands. He has published over 30 peer-reviewed papers, book chapters, and review articles. He has also filed several patents.[3]

Academic career

  • March 1989 – February 1993: Teaching assistant, department of biochemistry, school of medicine, KNU, South Korea
  • May 1993 – April 1996: Primary physician, Public Health Center of Changyeong-gun, Gyeongju, South Korea
  • March 1996 – February 1998: Instructor, department of biochemistry, school of medicine, Dongguk University, Gyeongju, South Korea
  • June 1997 – August 1997: Visiting investigator, MD Anderson Cancer Center, Houston, Texas, United States
  • October 1998 – February 2002: Assistant professor, department of biochemistry, school of medicine, Dongguk University, Gyeongju, South Korea
  • February 2001 – July 2003: Visiting investigator, The Burnham Institute for Medical Research, San Diego, United States
  • August 2003 – present: Professor, department of biochemistry and cell biology, school of medicine, KNU, South Korea; associate dean for research and international programs, school of medicine, KNU, South Korea

Professional memberships

  • 1989–present: Korean Society of Molecular Biology and Biochemistry
  • 1990–present: Korean Society of Molecular Cell Biology
  • 2003–present: American Association for Cancer Research
  • 2005–present: American Society of Molecular Imaging

Research interests

Phage display selection of tissue-specific homing peptides and biomarker-sensing peptides: Phage peptide display is a powerful tool for identifying peptides that selectively bind to a target protein or cells (see figure below). Using this technology, our lab has identified diverse homing peptides, including the bladder tumor-targeting peptide, atherosclerotic plaque-homing peptide, and IL-4 receptor-binding peptide. We also have been working on selecting peptides that specifically recognize or sense biomarker proteins of cardiovascular diseases and cancers.

Recent publications

Patents

  • Peptides for targeting apoptotic cells and uses thereof US 8217012  KR 20100029232  JP 2009273462  EP 2279201  CN 102177174 
  • Polypeptide specifically bound to phosphatidylserine and the use thereof US 8133971  KR 20090091589  JP 2011515075  EP 2280024  CN 101965356 
  • Peptide for diagnosing, preventing and treating atherosclerosis and uses thereof US 7968081  KR 20080090610 
  • Bladder tumor-targeting peptide and use thereof US 7745410 
  • Use of a peptide that interacts with alphaV beta3 integrin of endothelial cells EP 1620122 
  • Novel use of isolated polypeptide comprising four FAS-1 domains, EM1 domain and RGD motif US 2008274955  WO 2005099743 
  • Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof US 2012294931  EP 520281  KR 20110076836 
  • Peptide which passes through blood-brain barrier and targets apoptosis of neurodegenerative brain disease site and uses thereof US 2012288447  KR 20110053119  WO 2011059263 
  • Uses of apoptotic cell-targeting peptides, label substances and liposomes containing a therapeutic agent for preventing, treating or therapeutically diagnosing apoptosis-related diseases WO 2011059262 
  • Stroke-targeting peptide and use thereof US 2011150764  KR 20090125440 

Current lab members

  • Gowri Rangaswamy Gunassekaran: Post-doctoral fellow (from India)
  • Guruprasath Padmanaban : PhD student (from India)
  • Jung Hyun-Kyung (정현경): PhD student (from South Korea)
  • Chi Lianhua : PhD student (from China)
  • Sri Murugan Poongkavithai Vadevod: PhD student (from India)
  • Md. Enamul Haque: PhD student (from Bangladesh)
  • Fatima Khan: PhD student (from India)
  • Smirti Gurung: PhD student (from India)
  • Lee Ji-young (이지영): lab manager

Past lab members

  • Sangeetha Purushotham: Post-doctoral fellow (from India)
  • Bodhraj Acharya: post-doctoral fellow (from Nepal)
  • Kai Wang: post-doctoral fellow (from China)
  • Jung Jae-Yeop (정재엽): Master's student (from South Korea)
  • Jung Joo-Hee (정주희): Master's student (from South Korea)
  • Jung Yu-Min (정유민):Master's student (from South Korea)

References

  1. ^ 경북대학교 의과대학 생화학·세포생물학 교실. Biochem.knu.ac.kr. Archived from the original on 2004-10-09. Retrieved 2012-11-01.
  2. ^ 경북대학교 세포.기질연구소. cmbl.knu.ac.kr/. Archived from the original on 2014-08-08. Retrieved 2013-09-16.
  3. ^ "nanoHUB.org - members: View: Byung-Heon Lee". nanohub.org. Retrieved 2013-09-15.